Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
3
×
boston blog main
boston top stories
clinical trials
life sciences
national blog main
fda
abbvie
access biotechnology
access industries
alexion pharmaceuticals
ally bridge group
amyotrophic lateral sclerosis (als)
anemia
atlas ventures
autoimmune disorders
big data analytics
blackrock
blood diseases
blood disorders
brian macdonald
casdin capital
complement system
deals
diabetic nephropathy
disc medicine
drug development
elizabeta nemeth
eventide asset management
financing
focal segmental glomerulosclerosis
generalized myasthenia gravis
goldfinch bio
immune-mediated necrotizing myopathy
incubation
irving investors
jay ghosh
licensing
merganser biotech
What
lead
3
×
drug
medicines
new
advance
alternative
analysis
anemia
autoimmune
bio
biotech
blood
body
bring
candidate
carry
cells
company
deal
develop
disc
disease
diseases
employing
expensive
genetic
goldfinch
having
health
ipo
iron
kidney
later
launches
little
lungs
medicine
million
need
oxygen
Language
unset
Current search:
lead
×
boston
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Disc Medicine Launches With $50M to Advance New Anemia Treatments
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
